Zhejiang Hisoar Pharmaceutical Co., Ltd. (SHE:002099)

China flag China · Delayed Price · Currency is CNY
5.47
+0.25 (4.79%)
Jul 29, 2026, 3:04 PM CST
Market Cap8.56B -12.0%
Revenue (ttm)1.86B -1.9%
Net Income-73.86M
EPS-0.05
Shares Out 1.56B
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume30,903,997
Open5.14
Previous Close5.22
Day's Range5.14 - 5.55
52-Week Range4.87 - 9.09
Beta0.36
Analystsn/a
Price Targetn/a
Earnings DateAug 29, 2026

About SHE:002099

Zhejiang Hisoar Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of active pharmaceutical ingredients (APIs) and pharmaceutical intermediates in China and internationally. It operates through Pharmaceutical Industry, Dye Industry, and Others segments. The company offers antibiotics, cardiovascular drugs, hypoglycemic agents, formulations, and fine chemicals. It also provides dyes and pigment intermediates; environmental protection-related equipment; medical chemical supplies an... [Read more]

Sector Healthcare
Founded 1966
Employees 2,736
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002099
Full Company Profile

Financial Performance

In 2025, SHE:002099's revenue was 1.86 billion, a decrease of -4.01% compared to the previous year's 1.94 billion. Losses were -91.08 million, -72.42% less than in 2024.

Financial Statements